Brussels, Belgium

Geert Meersseman

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 2.6

ph-index = 1


Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Geert Meersseman

Introduction

Geert Meersseman, an accomplished inventor based in Brussels, Belgium, holds a remarkable portfolio of three patents. His innovative spirit and dedication to advancing scientific methods have led to significant contributions in the field of molecular biology and automated systems.

Latest Patents

Meersseman's latest patents showcase his expertise in optimizing clinical sample sequencing. One notable patent describes an automated system capable of performing quantitative PCR (qPCR) analysis of nucleic acids in biological samples while simultaneously or sequentially preparing sequencing-ready nucleic acid libraries. Additionally, this invention includes the development of removable cartridges for use in these automated systems.

Another noteworthy patent details an automatable method for nucleic acid isolation, specifically designed for nucleic acids shorter than 250 base pairs. This method can be accomplished without a proteolytic pre-digestion step in a cartridge-based automated system. Furthermore, Meersseman's innovations extend to automated nucleic acid detection methods, complete with buffers and kits tailored for these processes.

Career Highlights

Throughout his career, Geert has contributed to the success of prominent companies in the biotechnology sector, including Biocartis and Lonza Biologics. His work has been instrumental in advancing various projects that utilize his patented technologies, demonstrating a commitment to improving diagnostic and analytical capabilities.

Collaborations

Collaborating with notable professionals such as Klaas DeCanniere and Johan Desmet, Meersseman has continued to expand his influential network within the research community. These collaborations have fostered an environment of innovation, pushing the boundaries of what is possible in molecular diagnostics.

Conclusion

Geert Meersseman's contributions to the field of automated nucleic acid analysis exemplify the profound impact of innovative thinking in science and technology. His patents not only enhance laboratory efficiency but also pave the way for future advancements in medical diagnostics and research. Through his work, Meersseman stands as a testament to the power of invention in addressing complex scientific challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…